Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis C virus infected patients. Results in real clinical practice

OBJECTIVES: Direct-acting antivirals have shown high efficacy in all hepatitis C virus (HCV) genotypes, but genotype 3 (G3) treatments continue to be a challenge, mainly in cirrhotic patients. The aim of this study is to analyse effectiveness and safety of daclatasvir associated with sofosbuvir with...

Descripción completa

Detalles Bibliográficos
Autores principales: Margusino-Framiñán, Luis, Cid-Silva, Purificación, Mena-de-Cea, Álvaro, Rodríguez-Osorio, Iria, Pernas-Souto, Berta, Delgado-Blanco, Manuel, Pertega-Díaz, Sonia, Martín-Herranz, Isabel, Castro-Iglesias, Ángeles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2019
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441991/
https://www.ncbi.nlm.nih.gov/pubmed/30761823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441991/
https://www.ncbi.nlm.nih.gov/pubmed/30761823

Ejemplares similares